Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. (Q45959509)
Jump to navigation
Jump to search
scientific article published in March 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. |
scientific article published in March 2006 |
Statements
1 reference
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. (English)
1 reference
Robert L Avery
1 reference
1 March 2006
1 reference
1 reference
26
1 reference
3
1 reference
352-354
1 reference